금융 뉴스 허브

M&T Bank (MTB): Buy, Sell, or Hold Post Q1 Earnings?

M&T Bank’s 14.5% return over the past six months has outpaced the S&P 500 by 6.5%, and its stock price has climbed to $239.99 per share. This run-up might have investors contemplating their next move.

Oil: Gulf supply recovery challenges oversupply narrative – Commerzbank

Commerzbank’s Carsten Fritsch highlights a rapid recovery in Gulf oil production and exports following the US–Iran agreement, with Brent moving into contango and Saudi Arabia slashing its OSP for Asia ...

Consumers' moods dim on short-, medium-term inflation but brighten on job prospects

Argan Trades at a Premium: Should Investors Buy the Stock or Wait?

Can rising power demand, strong project execution and data center growth justify AGX's premium valuation, or should investors wait?

Six Key Issues to Watch at NATO’s Ankara Summit

NATO leaders are meeting in the Turkish capital, Ankara, for the alliance’s annual summit on July 7-8 in the shadow of the Iran war and American complaints that not all European allies are pulling the ...

3 Reasons Investors Love Nubank (NU)

Over the past six months, Nubank’s shares (currently trading at $14.06) have posted a disappointing 19.7% loss, well below the S&P 500’s 8% gain. This might have investors contemplating their next mov ...

LUNR Falls 36.5% in the Past Month: How to Play the Stock?

Intuitive Machines' 36.5% monthly drop raises questions as NASA-backed lunar growth prospects are weighed against losses, execution risks and premium valuation.

3 AI Stocks That Could Outperform the S&P 500 for Years to Come

These leading artificial intelligence companies still have room to run.

Renasant (RNST): Buy, Sell, or Hold Post Q1 Earnings?

Renasant has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13%. The stock now trades at $42.99, marking a 21% gain. This run-up might have investors contempla ...

NEXA Surges 164% in a Year: Should You Buy, Sell or Hold the Stock?

Nexa Resources surges 164% in a year as strong Q1 results, higher zinc output, growth investments and an attractive valuation support its long-term outlook.

Is Dave Stock a Buy, Hold or Sell After Its Recent Strong Rally?

DAVE's 46% monthly rally looks supported by raised guidance, improving credit trends, the Coastal funding deal and strong ExtraCash momentum.

UnitedHealth defends HouseCalls home-visit unit after external audit